Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus

Hepatocellular carcinoma (HCC) patients with main portal vein tumor thrombus have a median survival time of only about 4 months. We therefore compared the safety and efficacy of endovascular brachytherapy (EVBT) and sequential three-dimensional conformal radiotherapy (3-DCRT). From a cohort of 176 p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Yu, Tian-Zhu, Zhang, Wen, Liu, Qing-Xin, Li, Wen-Hui, Ma, Jing-Qin, Zhang, Zi-Han, Yang, Min-Jie, Wang, Jian-Hua, Chen, Bing, Zeng, Shao-Chong, Luo, Jian-Jun, Liu, Ling-Xiao, Yan, Zhi-Ping
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355329/
https://ncbi.nlm.nih.gov/pubmed/28076848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14520
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak